Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride

Bile acids (BAs) are a family of steroids synthesized from cholesterol in the liver. Among bile acids, ursodeoxycholic acid (UDCA) is the drug of choice for treating primary biliary cirrhosis and dissolving cholesterol gallstones. The clinical effectiveness of UDCA includes its choleretic activity,...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Zappaterra, F., Costa, S., Summa, D., Semeraro, B., Cristofori, V., Trapella, C., Tamburini, E.
Format: Article in Journal/Newspaper
Language:English
Published: 2021
Subjects:
Online Access:http://hdl.handle.net/11392/2464850
https://doi.org/10.3390/molecules26195966
https://www.mdpi.com/1420-3049/26/19/5966
https://pubmed.ncbi.nlm.nih.gov/34641510/
id ftunivferrarair:oai:iris.unife.it:11392/2464850
record_format openpolar
spelling ftunivferrarair:oai:iris.unife.it:11392/2464850 2024-02-11T09:57:53+01:00 Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride Zappaterra, F. Costa, S. Summa, D. Semeraro, B. Cristofori, V. Trapella, C. Tamburini, E. Zappaterra, F. Costa, S. Summa, D. Semeraro, B. Cristofori, V. Trapella, C. Tamburini, E. 2021 STAMPA http://hdl.handle.net/11392/2464850 https://doi.org/10.3390/molecules26195966 https://www.mdpi.com/1420-3049/26/19/5966 https://pubmed.ncbi.nlm.nih.gov/34641510/ eng eng info:eu-repo/semantics/altIdentifier/pmid/34641510 info:eu-repo/semantics/altIdentifier/wos/WOS:000707756200001 volume:26 issue:19 firstpage:5966-1 lastpage:5966-15 numberofpages:15 journal:MOLECULES http://hdl.handle.net/11392/2464850 doi:10.3390/molecules26195966 info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85116558195 https://www.mdpi.com/1420-3049/26/19/5966 https://pubmed.ncbi.nlm.nih.gov/34641510/ info:eu-repo/semantics/openAccess ursodeoxycholic acid monoglyceride esterification CALB prodrug info:eu-repo/semantics/article 2021 ftunivferrarair https://doi.org/10.3390/molecules26195966 2024-01-24T17:43:57Z Bile acids (BAs) are a family of steroids synthesized from cholesterol in the liver. Among bile acids, ursodeoxycholic acid (UDCA) is the drug of choice for treating primary biliary cirrhosis and dissolving cholesterol gallstones. The clinical effectiveness of UDCA includes its choleretic activity, the capability to inhibit hydrophobic bile acid absorption by the intestine under cholestatic conditions, reducing cholangiocyte injury, stimulation of impaired biliary output, and inhibition of hepatocyte apoptosis. Despite its clinical effectiveness, UDCA is poorly soluble in the gastro-duodeno-jejunal contents, and pharmacological doses of UDCA are not readily soluble in the stomach and intestine, resulting in incomplete absorption. Indeed, the solubility of 20 mg/L greatly limits the bioavailability of UDCA. Since the bioavailability of drug products plays a critical role in the design of oral administration dosages, we investigated the enzymatic esterification of UDCA as a strategy of hydrophilization. Therefore, we decided to enzymatically synthesize a glyceric ester of UDCA bile acid to produce a more water-soluble molecule. The esterification reactions between UDCA and glycerol were performed with an immobilized lipase B from Candida antarctica (Novozym 435) in solvent-free and solvent-assisted systems. The characterization of the UDCA-monoglyceride, enzymatically synthesized, has been performed by 1H-NMR, 13C-NMR, COSY, HSQC, HMBC, IR, and MS spectroscopy. Article in Journal/Newspaper Antarc* Antarctica Università degli Studi di Ferrara: CINECA IRIS Molecules 26 19 5966
institution Open Polar
collection Università degli Studi di Ferrara: CINECA IRIS
op_collection_id ftunivferrarair
language English
topic ursodeoxycholic acid
monoglyceride
esterification
CALB
prodrug
spellingShingle ursodeoxycholic acid
monoglyceride
esterification
CALB
prodrug
Zappaterra, F.
Costa, S.
Summa, D.
Semeraro, B.
Cristofori, V.
Trapella, C.
Tamburini, E.
Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
topic_facet ursodeoxycholic acid
monoglyceride
esterification
CALB
prodrug
description Bile acids (BAs) are a family of steroids synthesized from cholesterol in the liver. Among bile acids, ursodeoxycholic acid (UDCA) is the drug of choice for treating primary biliary cirrhosis and dissolving cholesterol gallstones. The clinical effectiveness of UDCA includes its choleretic activity, the capability to inhibit hydrophobic bile acid absorption by the intestine under cholestatic conditions, reducing cholangiocyte injury, stimulation of impaired biliary output, and inhibition of hepatocyte apoptosis. Despite its clinical effectiveness, UDCA is poorly soluble in the gastro-duodeno-jejunal contents, and pharmacological doses of UDCA are not readily soluble in the stomach and intestine, resulting in incomplete absorption. Indeed, the solubility of 20 mg/L greatly limits the bioavailability of UDCA. Since the bioavailability of drug products plays a critical role in the design of oral administration dosages, we investigated the enzymatic esterification of UDCA as a strategy of hydrophilization. Therefore, we decided to enzymatically synthesize a glyceric ester of UDCA bile acid to produce a more water-soluble molecule. The esterification reactions between UDCA and glycerol were performed with an immobilized lipase B from Candida antarctica (Novozym 435) in solvent-free and solvent-assisted systems. The characterization of the UDCA-monoglyceride, enzymatically synthesized, has been performed by 1H-NMR, 13C-NMR, COSY, HSQC, HMBC, IR, and MS spectroscopy.
author2 Zappaterra, F.
Costa, S.
Summa, D.
Semeraro, B.
Cristofori, V.
Trapella, C.
Tamburini, E.
format Article in Journal/Newspaper
author Zappaterra, F.
Costa, S.
Summa, D.
Semeraro, B.
Cristofori, V.
Trapella, C.
Tamburini, E.
author_facet Zappaterra, F.
Costa, S.
Summa, D.
Semeraro, B.
Cristofori, V.
Trapella, C.
Tamburini, E.
author_sort Zappaterra, F.
title Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
title_short Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
title_full Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
title_fullStr Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
title_full_unstemmed Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
title_sort glyceric prodrug of ursodeoxycholic acid (udca): novozym 435-catalyzed synthesis of udca-monoglyceride
publishDate 2021
url http://hdl.handle.net/11392/2464850
https://doi.org/10.3390/molecules26195966
https://www.mdpi.com/1420-3049/26/19/5966
https://pubmed.ncbi.nlm.nih.gov/34641510/
genre Antarc*
Antarctica
genre_facet Antarc*
Antarctica
op_relation info:eu-repo/semantics/altIdentifier/pmid/34641510
info:eu-repo/semantics/altIdentifier/wos/WOS:000707756200001
volume:26
issue:19
firstpage:5966-1
lastpage:5966-15
numberofpages:15
journal:MOLECULES
http://hdl.handle.net/11392/2464850
doi:10.3390/molecules26195966
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85116558195
https://www.mdpi.com/1420-3049/26/19/5966
https://pubmed.ncbi.nlm.nih.gov/34641510/
op_rights info:eu-repo/semantics/openAccess
op_doi https://doi.org/10.3390/molecules26195966
container_title Molecules
container_volume 26
container_issue 19
container_start_page 5966
_version_ 1790593422635040768